Stay updated with breaking news from Williaml pridgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ProHealth By Donna Gregory Burch • ProHealth.com • January 25, 2021 ( 2020 was a quiet year for the fibromyalgia community when compared to Lyme or ME/CFS. There were no major headlines, and yet thousands of researchers, physicians and advocates worked behind the scenes, inching toward better treatments, testing and quality of life for fibromyalgia patients. Below is a summary of some of the most important fibromyalgia-related news stories from the past year. These small but mighty advances should lead to even more progress during 2021. New Fibromyalgia Drugs Are in the Pipeline NYX-2925: In September, biopharmaceutical company Aptinyx, Inc. resumed patient recruitment for a phase 2 study of NYX-2925, a novel N-methyl-D-aspartate receptor modulator, after temporarily halting the trial in March due to the COVID-19 pandemic. ....